Q5W274 AF NFT

Pleiotropic drug resistance protein 3

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibgfy65yt4dm5tvmpxpvv34dfiz4dwysied7htshr5rholn6xxfcm/metadata.json
IPFS of structure file: 
bafybeig3kh4wefonrtewt3yixzhc3tcrjwched34sll6l3pq7b6qzlcz3y/AF-Q5W274-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7a1388B6Aad67B04634A32f63b8A6D6005eab86c
First NFT owner address (bech32): 
genesis10gfc3d426easgc62xtmrhzndvqz74wrv0qh3l8
Current NFT ID #291053 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
291053
Accession (UniProt):
Q5W274
Name::
Pleiotropic drug resistance protein 3
Experimental Method:
Predicted structure
Sequence source:
NICOTIANA TABACUM

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q5W274 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q5W274|PDR3_TOBAC Pleiotropic drug resistance protein 3 OS=Nicotiana tabacum OX=4097 GN=PDR3 PE=2 SV=1 MAQLVGSDEIESFRMDLAEIGRSLRSSFRGQSSSFRSNSALSASQKDDAVDEENMLAWAAIERLPTFDRLRSSLFEEINGNDANVKRKRVTDVTKLGALERHVFIEKMIKHIEHDNLQLLHKIRKRIDKVGVELPTVEVRYKNLTIEAECELVHGKPLPTLWNSLKSITMNLARLPGLQSELAKIKILNDVSGVIKPGRMTLLLGPPGCGKTSLLKALSGNLDKSLKVSGEISYNGYKLEEFVPQKTSAYVSQNDLHIPEMTVRETLDYSSRFQGVGSRAEIMTDLSRREKEAGVVPDPDIDTYMKAISIEGQKKNLQTDYILKILGLDICADTLVGDAMRRGISGGQKKRLTTGELIVGPIKALFMDEISNGLDSSTTYQIVACLQQLAHITDATILVSLLQPAPETFDLFDDIILMAEGKILYHGPRNSALEFFESCGFKCPERKGVADFLQEVTSKKDQAQYWHGTKETYKFVSVDMLSRKFKESPYRKKLNEELSVPYDNSRSHRNSITFRDYSLPKWELFRACMSREFLLMKRNSFIYIFKTVQLAIIASITMTVFLRTRMDTDLVHANYYLGALFYALIILLVDGFPELSMTITRLAVFYKQSELCFYPAWAYTIPATILKIPLSLLESVIWASMTYYVIGFSPEAGRFFRQLLLLFAVHMTSISMFRFLASVCRTIVASTAAGGLSILFVLCFSGFIIPRPSMPIWLKWGFWISPLTYGEIGLAVNEFLAPRWQKTLPTNTSIGNEVLESRGLNFDGYFYWISVCALFGFTILFNIGFTLALTFLKAPGSRAIISTDKYSQIEGSSDSIDKADAAENSKATMDSHERAGRMVLPFEPLSLVFQDVQYYVDTPAAMTELGFTQKRLQLLSDITGALRPGILTALMGVSGAGKTTLLDVLAGRKTTGYVEGEIKVGGYPKVQETFARVSGYCEQTDIHSPQITVEESVIFSAWLRLHPQIDSKTKYEFVKEVIETIELDGIKGMLVGMPGVSGLSTEQRKRLTIAVELVANPSIIFMDEPTTGLDARSAAIVMRAVKNVADTGRTIVCTIHQPSIDIFEAFDELILLKTGGRMIYWGHLGRNSCKMIEYFEGISCVPKIKNNHNPATWMLEVTSTSSEADISIDFAEVYKNSALHKNNEELVKKLSFPPAGSKDLHFPTRFSQNGWGQFKTCFWKQYWSYWRSPSYNLMRSLHMLFASLVSGLLFWDKGKKLDNQQSVFSVFGAMFTAVIFCGINNSSSVLPYVTTERSVLYRERFAGMYASWAYALAQVAIEIPYLLAQALAFTVITYPMIGYYWSAYKVFWYFYSMFCTLLYFTYLGMMLVSMTPSFPVAAILQSSFYTMFNLFAGFLMPKAQIPKWWIWFYYLTPTSWTLNGMLTSQYGDIEKEITVFQEKKTVAAFLGDYFGFHHNQLPIVAFVLIAYPLVFASLFAFFIGKLNFQRR